Viewing nowRosuMed Tablet 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Telcon RF Pharmaceutical Co., Ltd.

MFDS item code 201908546 · Approved 2019.12.19 · Insurance code 625501130
Improvement of dyslipidemia, inhibition of the progression of atherosclerosis, and prevention of cardiovascular disease
This medication helps in cases where various lipid metabolism abnormalities, such as primary hypercholesterolemia and mixed hyperlipidemia, are difficult to control through diet and exercise. It is particularly effective in reducing total cholesterol and LDL-cholesterol levels when used in conjunction with dietary therapy or other treatments for patients with familial hypercholesterolemia, thereby delaying the progression of atherosclerosis. It may also be used as an adjunct in pediatric patients aged 10 to 17 years who meet certain criteria. Additionally, it helps supplement dietary therapy in patients with primary dysbetalipoproteinemia. In high-risk groups for cardiovascular disease, it contributes to the reduction of risks associated with cardiovascular events such as stroke, myocardial infarction, and arterial revascularization. Therefore, this medication is actively used to improve hyperlipidemia and cardiovascular risk.
1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased up to 20 milligrams once daily. 3. Elderly: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but exposure was increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 ∼ 17 years: The usual dose range is 5 milligrams ∼ 20 milligrams once daily. (There are no clinical data on administration of doses above 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Under 10 years: Safety and efficacy have not been established.
This medication should not be administered to certain patients. For example, those with allergies to any component of this medication, severely impaired liver function, muscle diseases, those taking certain immunosuppressants, and patients with severe kidney dysfunction should not use this medication. Pregnant or breastfeeding women, or fertile women who do not use adequate contraception should also avoid this medication, and women of childbearing age may only take it if pregnancy risk is low and they have been adequately informed of the potential risks to the fetus. Special care should be taken with patients at high risk for muscle-related side effects, and the dosage should be adjusted according to the physician's instructions due to the increased risk of muscle damage with high-dose use. This medication contains lactose, so patients with lactase deficiency or certain genetic metabolic disorders should not take it. Patients with impaired liver function or those who consume alcohol heavily should have regular liver function tests before and during treatment with this medication, and patients with hypercholesterolemia due to hypothyroidism or nephrotic syndrome must first treat the underlying disease. Should symptoms such as myalgia, muscle weakness, or cramps occur, the patient should immediately report this to their doctor and undergo blood tests to check for muscle damage, with possible discontinuation of the medication in severe cases. This medication may interact with certain drugs, so patients taking other medications must inform their physician or pharmacist. The risk of muscle damage may increase with co-administration of specific antiviral drugs, immunosuppressants, antifungals, antibiotics, and fibrate-class drugs. Pregnant or breastfeeding women should not use this medication, and women planning to become pregnant must use appropriate contraceptive methods. In cases of overdose, there is no specific antidote, and treatment should be symptomatic with liver function and muscle enzyme testing. Lastly, patients should be cautious when driving or operating machinery while taking this medication, as dizziness may occur.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnestic syndrome, memory impairment, confusion, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is safe to store at room temperature between 1 to 30 degrees Celsius.
Yellow round film-coated tablets
30 tablets/PTP[(15 tablets/PTP x 2 pieces)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Telcon RF Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.